Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development ...

Pfizer Completes Acquisition of Metsera

Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a ...

CT’s Pfizer acquires obesity drug start-up. A ‘strategic milestone,’ pharmaceutical giant CEO said

Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in ...
Yahoo

Pfizer Will Charge $1,390 For 1 Course Of COVID Drug Paxlovid On Commercial Market

Pfizer told pharmacies and clinics this week it will soon price a five-day course of COVID-19 treatment Paxlovid at almost $1,400, more than two-and-a-half times what the federal government has paid ...
Seeking Alpha

Pfizer touts cancer efforts in first Super Bowl commercial

Pfizer (NYSE:PFE) ran its first Super Bowl ad on Sunday, highlighting its efforts in oncology as the COVID-19 vaccine maker looks for post-pandemic growth following its recent acquisition of cancer ...

Pfizer Strengthens Pipeline With $10B Metsera Deal Amid Solid Q3 Results

Pfizer beats Q3 estimates, raises FY guidance, acquires Metsera for obesity drugs, and offers a 7% yield. Read here for an ...
The Pharma Letter

Pfizer scores a win for mRNA vaccines with influenza data

US pharma giant Pfizer has provided a reminder of the merits of mRNA-based vaccines as health leaders in the USA continue to question their safety.

Pfizer (PFE) Profit Margins Double—Challenges Bearish View Despite $4.7B Loss and Revenue Headwinds

Pfizer (PFE) posted notable earnings growth, with net profit margins improving to 15.6%, a lift from the previous period’s 7%. Year-over-year, EPS growth soared 133.3%, marking a sharp reversal from ...